Laura J. Parry

Laura J. Parry

Auto-generated profile, based on publicly available information

Laura J. Parry

Adelaide University

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Ross BathgateRoss Bathgate
Ross Bathgate
CSChrishan S. Samuel
Chrishan S. Samuel
TBTanya C. D. Burazin
Tanya C. D. Burazin
SLSharon Layfield
Sharon Layfield
ACAntonia A. Claasz
Antonia A. Claasz
GTGeoffrey W. Tregear
Geoffrey W. Tregear
We have identified a novel human relaxin gene, designated H3 relaxin, and an equivalent relaxin gene in the mouse from the Celera Genomics data base. Both genes encode a putative prohormone sequence incorporating the classic two-chain, three cysteine-bonded structure of the relaxin/insulin family and, importantly, contain the RXXXRXX(I/V) motif in the B-chain that is essential for relaxin receptor binding. A peptide derived from the likely proteolytic processing of the H3 relaxin prohormone sequence was synthesized and found to possess relaxin activity in bioassays utilizing the human monocytic cell line, THP-1, that expresses the relaxin receptor. The expression of this novel relaxin gene was studied in mouse tissues using RT-PCR, where transcripts were identified with a pattern of expression distinct from that of the previously characterized mouse relaxin. The highest levels of expression were found in the brain, whereas significant expression was also observed in the spleen, thymus, lung, and ovary. Northern blotting demonstrated an ∼1.2-kb transcript present in mouse brain poly(A) RNA but not in other tissues. These data, together with the localization of transcripts in the pars ventromedialis of the dorsal tegmental nucleus of C57BLK6J mouse brain by in situhybridization histochemistry, suggest a new role for relaxin in neuropeptide signaling processes. Together, these studies describe a third member of the human relaxin family and its equivalent in the mouse.

1 March 2016 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
FBFiona C. Brownfoot
Fiona C. Brownfoot
RHRoxanne Hastie
Roxanne Hastie
NHNatalie J. Hannan
Natalie J. Hannan
PCPing Cannon
Ping Cannon
LTLaura Tuohey
Laura Tuohey
STStephen Tong
Stephen Tong

1 November 2002 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
CSChrishan S. Samuel
Chrishan S. Samuel
CZChongxin Zhao
Chongxin Zhao
Ross BathgateRoss Bathgate
Ross Bathgate
CBCourtney P. Bond
Courtney P. Bond
MBMatthew D. Burton
Matthew D. Burton
GTGeoffrey W. Tregear
Geoffrey W. Tregear

1 February 2003 in Cardiovascular Research
Verified
Journal Article
Closed access
XDXiao-Jun Du
Xiao-Jun Du
CSChrishan S Samuel
Chrishan S Samuel
XGXiao-Ming Gao
Xiao-Ming Gao
LZLing Zhao
Ling Zhao
LPLaura J Parry
Laura J Parry
GTGeoffrey W Tregear
Geoffrey W Tregear
To investigate cardiac phenotypes in mice deficient in the peptide hormone relaxin by gene targeting. Echocardiography and cardiac catheterization were performed on male and female relaxin deficient (Rlx(-/-)) mice as well as heterozygous (Rlx(+/-)) and wildtype (Rlx(+/+)) littermates aged between 8 and 24 months. Collagen expression and content in the heart were analysed by real-time PCR, hydroxyproline assay and histology. Heart rate, blood pressures, left ventricular (LV) dimensions, fractional shortening and maximal and minimal dP/dt did not differ significantly between the three genotypes of either gender at any age. However, 8-10-month-old Rlx(-/-) males exhibited a greater transmitral flow velocity (A-wave) at the late LV diastolic phase. Male Rlx(-/-) mice aged between 12 and 24 months had significantly higher LV end-diastolic pressures, a 30% increase in atrial weight and 10-30% increases in lung and liver weights. Male mice also showed an age-dependent increase (P<0.01) in LV collagen content that was more pronounced in Rlx(-/-) than control littermates (P<0.01). Procollagen type-1 expression was also significantly higher in the LV of Rlx(-/-) males compared with either Rlx(+/-) or Rlx(+/+) males at 6, 9 and 12 months of age. Age-matched female Rlx(-/-) mice did not display any of these cardiac phenotypes seen in Rlx(-/-) males. Male Rlx(-/-) mice had impeded LV diastolic filling and increased atrial weights, most likely due to an increase in ventricular collagen content and chamber stiffness. These phenotypes in the Rlx(-/-) males were not observed in Rlx(-/-) females, indicating the importance of other gender-related factors in cardiovascular function.

30 January 2009 in The Journal of Physiology
Verified
Journal Article
Closed access
KNKathleen B. Neal
Kathleen B. Neal
LPLaura J. Parry
Laura J. Parry
JBJoel Bornstein
Joel Bornstein

1 November 2006 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JNJacqueline Novak
Jacqueline Novak
LPLaura J. Parry
Laura J. Parry
JMJulianna E. Matthews
Julianna E. Matthews
LKLaurie J. Kerchner
Laurie J. Kerchner
KIKimberly Indovina
Kimberly Indovina
KCKirk Conrad
Kirk Conrad
Relaxin is a 6 kDa protein hormone produced by the corpus luteum and secreted into the blood during pregnancy in rodents and humans. Growing evidence indicates that circulating relaxin causes vasodilatation and increases in arterial compliance, which may be among its most important actions during pregnancy. Here we investigated whether there is local expression and function of relaxin and relaxin receptor in arteries of nonpregnant females and males. Relaxin‐1 and its major receptor, Lgr7, mRNA are expressed in thoracic aortas, small renal and mesenteric arteries from mice and rats of both sexes, as well as in small renal arteries from female tammar wallabies (an Australian marsupial). Using available antibodies for rat and mouse Lgr7 receptor and rat relaxin, we also identified protein expression in arteries. Small renal arteries isolated from relaxin‐1 gene‐deficient mice demonstrate enhanced myogenic reactivity and decreased passive compliance relative to wild‐type (WT) and heterozygous mice. Taken together, these findings reveal an arterial‐derived, relaxin ligand‐receptor system that acts locally to regulate arterial function.—Novak, J., Parry, L. J., Matthews, J. E., Kerchner, L. J., Indovina, K., Hanley‐Yanez, K., Doty, K. D., Debrah, D. O., Shroff, S. G., Conrad, K. P. Evidence for local relaxin ligand‐receptor expression and function in arteries. FASEB J. 20, 2352–2362 (2006)